Is Halozyme Therapeutics (HALO) a Buy Post Earnings?

Halozyme Therapeutics, Inc. (NASDAQ:HALO) is one of the best cheap biotech stocks to buy now. Halozyme Therapeutics, Inc. (NASDAQ:HALO) has received several bullish rating updates from analysts following its earnings release. Morgan Stanley lifted the price target on the stock to $94 from $78 on February 19, maintaining an Overweight rating on the shares after Halozyme Therapeutics, Inc. (NASDAQ:HALO) reported “strong” Q4 results. It told investors in a research note that it believes 2026 to be “another strong year,” driven by royalty revenues, expanding ENHANZE partnerships, and progressing Hypercon and Surf Bio tech after the acquisitions.

In addition to Morgan Stanley, Benchmark also lifted the price target on Halozyme Therapeutics, Inc. (NASDAQ:HALO) to $90 from $75 on February 19 and reiterated a Buy rating on the shares after what the firm described as “strong quarterly results and positive forward guidance.” The same day, Wells Fargo also raised the price target on Halozyme Therapeutics, Inc. (NASDAQ:HALO) to $75 from $65, reaffirming an Equal Weight rating on the shares and telling investors that it sees the company’s near-term outlook as stable, driven by robust growth from Vyvgart and Darzalex.

Halozyme Therapeutics, Inc. (NASDAQ:HALO) is a biopharmaceutical technology platform company that develops, manufactures, and commercializes drug-device combination products through advanced auto-injector technology. They offer commercial or functional benefits, including increased patient comfort and adherence, and enhanced tolerability and convenience.

While we acknowledge the potential of HALO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.